University of California, Los Angeles (UCLA)
Los Angeles, California, 90095, United States
NCT Number: NCT03603886
Pain in adolescents undergoing treatment for cancer is a common problem, often related to treatment or to the cancer itself. Due to increasing outpatient-based cancer treatment, the burden of care and pain management has shifted to the home environment. Yet, there are limited interventions that target the management of pain at home. Adolescence is marked by increased need for independence and social integration, both of which can be impaired by pain or fear of pain. To address unique needs during this developmental period, this study will test a telemedicine program to enhance pain knowledge and pain control strategies in adolescents ages 12-21 years who are undergoing treatment for cancer.
Fifty-six teens will be randomized to an intervention or wait-list control condition. Patients randomized to the waitlist control condition will receive the intervention following completion of the waitlist condition. The intervention will consist of four weekly 30-45 minute telemedicine (online via videoconferencing platform) sessions with a trained social work or psychology provider. Sessions will focus on pain psychoeducation, coping tools, communication, and stress management. Participants will complete online questionnaires assessing pain coping, pain management, and pain-related impairment at pre-intervention, post-intervention, and 1- and 2-month follow-up.
Looking for future studies?
Notify MeHealthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Four weekly telemedicine pain management sessions with a trained provider. Intervention will be delivered via video conferencing platform, and each session will last between 30 and 45 minutes. Intervention topics will include: pain psychoeducation, pain coping tools, pain communication, and pain-related stress management.
Four week waitlist period during which participants receive treatment as usual. Following the waitlist period, participants will receive the telemedicine pain management intervention:
Four weekly telemedicine pain management sessions with a trained provider. Intervention will be delivered via video conferencing platform, and each session will last between 30 and 45 minutes. Intervention topics will include: pain psychoeducation, pain coping tools, pain communication, and pain-related stress management.
Time frame: Within 7 days of withdrawing from or completing the intervention
Determined by the percentage of participants who drop out of the study. An attrition rate of 20% or less will indicate feasibility.
Time frame: Within 7 days of withdrawing from or completing the intervention
Determined by the number of sessions that participants attend (out of 4 total sessions). To be considered feasible, 80% of participants must have completed at least 3 of the sessions within a 6-week period.
Time frame: Within 7 days of completing the intervention
Intervention will be deemed acceptable if at least 80% of participants rate each question an average of at least "4" ("Agree") on a 5-point scale anchored by "Strongly Disagree" and "Strongly Agree."
Time frame: At study enrollment (pre-intervention) and between 4 and 6 weeks later (post-intervention for immediate group, post-waitlist period for waitlist group)
Assessed by the change in the total score on the 'Coping with Pain' section of the Pain Coping Questionnaire (PCQ) from pre-intervention to post-intervention (immediate group) or post-waitlist period (waitlist group). Calculated by subtracting the pre-intervention score from the post-intervention score. The 'Coping with Pain' section of the PCQ consists of 39 items. The total score is calculated as a mean rating and can range from 1-5 and higher scores indicate greater use of coping strategies.
Time frame: At study enrollment (pre-intervention) and between 4 and 6 weeks later (post-intervention for immediate group, post-waitlist period for waitlist group)
Assessed by the change in the total score on the PROMIS Pain Interference - Pediatric Short Form v2.0 from pre-intervention to post-intervention (immediate group) or post-waitlist period (waitlist group). Calculated by subtracting the pre-intervention score from the post-intervention score. The PROMIS Pain Interference - Pediatric Short Form v2.0 is an 8-item measure whose total score can range from 8-40. Higher scores indicate higher interference caused by pain.
University of California, Los Angeles
Other
Telemedicine Pain Control Program for Teens Undergoing Treatment for Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05364372
Behavior, Cancer
Tucson, Arizona, United States
View Trial DetailsNCT01445483
Brain Diseases, Brain Metastasis
Bethesda, Maryland, United States
View Trial DetailsNCT00038727
Body Weight, CVD
Rockville, Maryland, United States
View Trial DetailsNCT03556384
Brain Diseases, Cancer
La Jolla, California, United States
View Trial Details